Snowmass Ophthalmology

| Monday 22nd | Topics of Discussion | Speakers | Morning Moderated By |
| 7:30am-8:00am | Secondary glaucoma's-unique issues in diagnosis and management tips from early experiences with the Express shunt | Gayle Howard, MD | Gayle Howard, MD |
| 8:00am-8:30am | Evolving Strategies for the Management of Diabetic Retinopathy | Steve Charles, MD | |
| 8:30am-9:00am | Cataracts and Glaucoma | Jon Ruderman, MD | |
| 4:15pm-4:45pm | Vitreomacular Surgery | Steve Charles, MD | Afternoon Moderated By |
| 4:45pm-5:15pm | The use of Administrative healthcare claims databases to study patients with ocular diseases | Joshua Stein, MD | Steve Charles, MD |
| 5:15pm-6:15pm | Narrow angles-laser iridectomy or cataract surgery (opinions & discussion). | Gayle Howard, MD | |
| 6:15pm-6:45pm | Management of Dropped Nucleus & Vitreous Loss at Cataract Surgery | Steve Charles, MD | |
| Tuesday 23rd | Morning Moderated By | ||
| 8:00am-8:30am | New medications to treat glaucoma: what is needed? | Charles Tressler, MD | Charles Tressler, MD |
| 8:30am-9:00am | What's new in tonometery | Robert Stamper, MD | |
| 4:45pm-5:15pm | Anti-VEGF Therapy in Glaucoma Patients | Malik Kahook, MD | Afternoon Moderated By |
| 5:15pm-6:15pm | "Rethinking Glaucoma Surgery: ELT Present & Future." | Michael Berlin, MD | Collen Coleman, MD |
| 6:15pm-6:45pm | The Role of Endothelin in Treating Glaucoma | Malik Kahook, MD | |
| Wednesday 24th | Morning Moderated By | ||
| 7:30am-8:00am | What constitutes an optimal ocular delivery system? | Charles Tressler, MD | Collen Coleman, MD |
| 8:00am-9:00am | Four generations of trabeculoplasty: ALT,SLT,MDLT, Saphire Titanium and beyond | John Samples, MD | |
| 4:45pm-5:45pm | New surgical approaches in glaucoma | Robert Stamper, MD | Afternoon Moderated By |
| 5:45pm-6:45pm | Risk/benefit ratios of glaucoma surgeries, lasers, and drugs | Charles Tressler, MD | John Samples, MD |
| Thursday 25th | Morning Moderated By | ||
| 7:30am-8:00am | Glaukos iStent | Mike Stiles, MD | Joshua Stein, MD |
| 8:00am-8:30am | What's important? Mean IOP/MaxIOP/or fluctuation | Robert Stamper, MD | |
| 8:30am-9:00am | Antifibrotics and Glaucoma Surgery | Jon Ruderman, MD | |
| 4:15pm-4:45pm | Who are the costliest eye Care patients? | Joshua Stein, MD | Afternoon Moderated By |
| 4:45pm-6:15pm | Point Counterpoint with Dr. Frenkel- What is more important in evaluating the Optic Nerve? The intruments or the clinician? | Joshua Stein, MD | Michael Berlin, MD |
| 6:15pm-6:45pm | Glaucoma and uveitis: Much more complicated than you think. | John Samples, MD | |
| Friday 26th | Morning Moderated By | ||
| 7:30am-8:30am | Trabectome and Canaloplasty: Their Role in Glaucoma Management | Mike Stiles, MD | Mike Tolentino, MD |
| 8:30am-9:00am | Potential unintended consequences of anti-VEGF therapy for exudative AMD | Mike Tolentino, MD | |
| 4:15pm-4:45pm | Controversial topic | Mike Stiles, MD | Afternoon Moderated By |
| 4:45pm-5:15pm | New paradigm treatments shifts for treatment of ischemic retinal diseases | Mike Tolentino, MD | Ronald Frenkel, MD |
| 5:15pm-5:45pm | Review and treatment of Neovascular Glaucoma | Collen Coleman, MD | |